Shots: Arcus to receive $375M including $175M up front & $200M as equity investment at a price of $33.54/ share with a premium of 35% and is eligible to receive […]readmore
Tags : Co-Commercialize
Shots: Adaptimmune to receive $50M up front, ~73.75M development milestones/ target (if product co-developed & co-commercialized by both companies) and $147.5M as milestones/product & $110M as commercial milestone if products […]readmore
Shots: Vifor and Janssen collaborated to jointly commercialize Invokana (canagliflozin) to treat DKD and to reduce the risk of hospitalization for heart failure in patients with T2D and DKD in […]readmore
Shots: Glenmark to receive up front, license fee and royalties on sales and is responsible to manufacture and supply Remogliflozin. Torrent to get rights to commercialize Remogliflozin under the trademark […]readmore